Stocktoria
ImageneBio, Inc. IMA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-03-26
Chart by TradingView
2/9
Piotroski F — financial health
5.55
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $800,000 | $3.5M | $9.2M | $15.6M | $31.0M |
| Operating income | -$48.5M | -$37.0M | -$75.4M | -$70.9M | -$34.1M |
| Net income | -$45.3M | -$36.6M | -$68.2M | -$68.8M | -$34.1M |
| Operating cash flow | -$47.8M | -$21.3M | -$79.7M | -$74.1M | -$60.3M |
| Free cash flow | — | — | -$80.2M | -$75.5M | -$62.0M |
| Total assets | $153.0M | $15.9M | $192.1M | $172.3M | $247.9M |
| Total liabilities | $19.8M | $17.4M | $22.3M | $25.3M | $40.0M |
| Shareholders' equity | $133.1M | -$160.6M | -$126.1M | $147.0M | $207.9M |
| Ratios | |||||
| Operating margin | -6056.4% | -1057.1% | -823.3% | -454.0% | -110.2% |
| Net margin | -5668.6% | -1044.8% | -744.2% | -440.3% | -110.1% |
| FCF margin | — | — | -875.1% | -483.7% | -200.1% |
| Return on assets | -29.6% | -229.7% | -35.5% | -39.9% | -13.8% |
| Return on equity | -34.1% | 22.8% | 54.1% | -46.8% | -16.4% |
| Current ratio | 12.49 | 0.72 | 12.58 | 7.44 | 8.70 |
| Revenue growth | -77.1% | -61.8% | -41.3% | -49.6% | 237.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 81,696 | $408,480 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.55 (safe)
- Working capital / assets 0.844
- Retained earnings / assets -1.504
- EBIT / assets -0.317
- Equity / liabilities 6.712
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001835579 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.